NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases

The Lancet. Oncology

Volumn 17, Issue 3, 2016, Pages 275-276

  Umeweni, Nwamaka ^a   Knight, Helen ^a   McVeigh, Gary ^a  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; RADIUM; RADIUM CHLORIDE RA 223;

AGED; BONE NEOPLASMS; DISEASE FREE SURVIVAL; GREAT BRITAIN; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RISK ASSESSMENT; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RADIOISOTOPES; RADIUM; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85027958878     PISSN: None     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)00060-7     Document Type: Note

References (0)